Bio-Path Holdings (NQ: BPTH )
1.610 +0.040 (+2.55%) Streaming Delayed Price Updated: 3:59 PM EDT, Mar 27, 2023 Add to My Watchlist
Headline News about Bio-Path Holdings
Bio-Path Holdings Q3 2022 Earnings Conference Call On November 15, 2022 At 08:30 AM ET
December 06, 2022
Bio-Path Holdings (NASDAQ:BPTH) will host a conference call at 08:30 AM ET on November 15, 2022, to discuss Q3 2022 earnings results. How to Attend Bio-Path Holdings (BPTH) Conference Call Follow this...
12 Health Care Stocks Moving In Monday's Intraday Session
November 07, 2022
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
May 17, 2022
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 13, 2022
The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China
March 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Valneva Says Confident Of Conditional Approval For COVID Vaccine Candidate In...
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following